Efeitos do ATP e dos receptores purinérgicos da área A5 na neurotransmissão do quimiorreflexo em ratos não-anestesiados

Detalhes bibliográficos
Ano de defesa: 2015
Autor(a) principal: Sílvia Amaral Zebral
Orientador(a): Não Informado pela instituição
Banca de defesa: Não Informado pela instituição
Tipo de documento: Dissertação
Tipo de acesso: Acesso aberto
Idioma: por
Instituição de defesa: Universidade Federal de Minas Gerais
Brasil
ICB - INSTITUTO DE CIÊNCIAS BIOLOGICAS
Programa de Pós-Graduação em Ciências Biológicas - Fisiologia e Farmacologia
UFMG
Programa de Pós-Graduação: Não Informado pela instituição
Departamento: Não Informado pela instituição
País: Não Informado pela instituição
Palavras-chave em Português:
Link de acesso: http://hdl.handle.net/1843/55227
Resumo: The aim of this study was to evaluate the possible involvement of purinergic P2 receptors in the A5 area on arterial blood pressure and heart rate control and on cardiovascular responses to peripheral chemoreflex activation in non-anesthetized rats. We observed that the microinjection of α,β-methylene ATP [0.625 and 1.25 nmol/100nl - P2X receptor agonist) induced an increase in mean arterial pressure (+0.0±0.5 vs. +25±5 and +25±3 mmHg) and heart rate (+0.9±2 vs. +39±9 and +56±10 bpm) when compared to the effects induced by the vehicle (n=8, p<0.05). The pressor and tachycardia responses induced by α,β-methylene ATP (1.25nmol/100nl) were reduced (+33±6 vs. +14±5 mmHg and +70±11 vs. +27±13 bpm) by the previous microinjection of the P2 receptors antagonist, PPADS (Pyridoxal-phosphate-6-azophenyl-2’,4’-disulfonate - 0.5nmol/100nl). However, bilateral microinjection of PPADS (0.5nmol/100nl) in the A5 area produced no changes in pressor (+38±6 vs. +39±6; +43±4; +41±3; +40±2; +37±5 mmHg) and bradycardic responses (-253±8 vs. -237±25; -248±12; -250±17; -251±13 and 253±17 bpm) of the chemoreflex when compared with the control response (n=5, p>0.05). Similarly to the isolated blockade, the simultaneous blockade of purinergic P2 and ionotropic glutamate receptors by sequential microinjection of the antagonists PPADS (0.25nmol/50nl) and kinurenic acid (2nmol/50nl) in the A5 area of non anesthetized rats promoted no significant changes in pressor (+49±3 vs +41±4; +46±5; +47±4; +44±3, +47±4 mmHg) and bradycardic (-252±23 vs -259±28; 250±11; -268±11; -260±10; -259±14 bpm) responses of chemoreflex (n=6, p>0.05). Our results show for the first time that purinergic P2 receptors in the A5 area participate of blood pressure and heart rate control. However, the purinergicreceptors, alone or combined with ionotropic glutamate receptors, do not participate in the integration of cardiovascular responses of the chemoreflex in non-anesthetized rats.